Exploring Key Insights of the Macular Degeneration Treatment Market: Growth Prospects, Emerging Trends, and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the macular degeneration treatment market grown over the years?
Recent years have seen a rapid expansion in the market size for macular degeneration treatment. Projected growth indicates that the market will increase from $11.05 billion in 2024 to $12.42 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 12.4%. Factors contributing to growth during the historical period include an aging population, changes in lifestyle, limited treatment availability, heightened awareness, and the development of healthcare infrastructure.
What Is the forecasted market size and growth rate for the macular degeneration treatment market?
Get your macular degeneration treatment market report here!
What are the major factors driving growth in the macular degeneration treatment market?
The rising prevalence of retinal diseases is anticipated to boost the macular degeneration treatment market’s progress. These eye-related conditions adversely influence the crucial tissue pivotal for visual information processing, resulting in distorted or completely missing vision. As an illustrative example, data from the American Academy of Ophthalmology indicates that by the time we get to 2050, an approximation of 7.32 million US residents will be diagnosed with primary open-angle glaucoma, an umbrella term for a collective of eye diseases. The highest rates will be seen among individuals aged between 70 to 79 years (32%), females (50%), and Hispanics (50%), with Hispanic men making up the majority demographic. This amplifying occurrence of retinal ailments is consequently fuelling the expansion of the macular degeneration treatment market.
What key areas define the segmentation of the global macular degeneration treatment Market?
The macular degeneration treatment market covered in this report is segmented –
1) By Stage of Disease: Early-Stage AMD, Intermediate AMD, Late-Stage AMD
2) By End User: Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals
3) By Route of Administration: Oral, Injectable, Other Route of Administration
4) By Types: Wet Macular Degeneration, Dry Macular Degeneration
Subsegments:
1) By Early-Stage AMD: Nutritional Supplements, Lifestyle Modification Treatments
2) By Intermediate AMD: Anti-VEGF Injections, Photodynamic Therapy
3) By Late-Stage AMD: Surgical Treatments, Advanced Anti-VEGF Therapies, Gene Therapy Options
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5799&type=smp
What are the top market players propelling the growth of the macular degeneration treatment industry?
Major companies operating in the macular degeneration treatment market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Allergan Inc., Bayer AG, Novartis AG, GlaxoSmithKline plc, Panoptica, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Santen Pharmaceuticals, Aerie Pharmaceuticals Inc., BioXcel Therapeutics Inc., Regenxbio Inc., Spark Therapeutics Inc., Alimera Sciences Inc., Applied Genetic Technologies Corp (AGTC), Cell Medica Ltd., Ophthotech Corporation, Adverum Biotechnologies Inc., Neurotech Pharmaceuticals Inc., 4D Molecular Therapeutics Inc., GenSight Biologics Inc.
What are the key trends shaping the future of the macular degeneration treatment market?
A variety of prominent enterprises in the macular degeneration treatment business include Pfizer Inc., F. Hoffmann-La Roche Ltd., Allergan Inc., Bayer AG, Novartis AG, GlaxoSmithKline plc, Panoptica, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Santen Pharmaceuticals, Aerie Pharmaceuticals Inc., BioXcel Therapeutics Inc., Regenxbio Inc., Spark Therapeutics Inc., Alimera Sciences Inc., Applied Genetic Technologies Corp (AGTC), Cell Medica Ltd., Ophthotech Corporation, Adverum Biotechnologies Inc., Neurotech Pharmaceuticals Inc., 4D Molecular Therapeutics Inc., GenSight Biologics Inc.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5799
What regions are dominating the macular degeneration treatment market growth?
North America was the largest region in the macular degeneration treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the macular degeneration treatment Market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Gastrointestinal Bleeding Treatment Devices Global Market Report 2024
Hemodialysis And Peritoneal Dialysis Global Market Report 2024
Endoscopy Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
